The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
In this study, a comparative analysis of metal-related neuronal vulnerability was performed in two brainstem nuclei, the locus coeruleus (LC) and substantia nigra (SN), known targets of the etiological noxae in Parkinson's disease and related disorders. LC and SN pars compacta neurons both degenerate in Parkinson's disease and other Parkinsonisms; however, LC neurons are comparatively less affected and with a variable degree of involvement. In this study, iron, copper, and their major molecular forms like ferritins, ceruloplasmin, neuromelanin (NM), manganese-superoxide dismutase (SOD), and copper/zinc-SOD were measured in LC and SN of normal subjects at different ages. Iron content in LC was much lower than that in SN, and the ratio heavy-chain ferritin/iron in LC was higher than in the SN. The NM concentration was similar in LC and SN, but the iron content in NM of LC was much lower than SN. In both regions, heavy- and light-chain ferritins were present only in glia and were not detectable in neurons. These data suggest that in LC neurons, the iron mobilization and toxicity is lower than that in SN and is efficiently buffered by NM. The bigger damage occurring in SN could be related to the higher content of iron. Ferritins accomplish the same function of buffering iron in glial cells. Ceruloplasmin levels were similar in LC and SN, but copper was higher in LC. However, the copper content in NM of LC was higher than that of SN, indicating a higher copper mobilization in LC neurons. Manganese-SOD and copper/zinc-SOD had similar age trend in LC and SN. These results may explain at least one of the reasons underlying lower vulnerability of LC compared to SN in Parkinsonian syndromes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Locus coeruleus neurons contain norepinephrine-derived neuromelanin (227, 228); the dorsal motor nucleus of vagus contains neuromelanin that may be dopaminergic (202); and the raphe nuclei contain neuromelanin derived from their neurotransmitter, serotonin.”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [228]
In the citing paper
“In healthy ageing, selective accumulation of iron occurs in several brain regions and cell types, with iron mainly bound within ferritin and neuromelanin (panel).5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Neuromelanin is present in neurons as neuromelanin-iron complexes in which the iron content varies depending on the neurons in each brain area.6,53”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Regional distribution of total iron in a healthy adult brain is heterogeneous; the highest iron concentrations were detected in the basal ganglia (putamen, globus pallidus, and caudate nucleus), whereas low concentrations were detected in the cortical grey matter, white matter, midbrain, and cerebellum, and the lowest iron concentrations were in the pons, locus coeruleus, and medulla.6,43,45–47”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“In the substantia nigra, ferritin heavy chain and ferritin light chain concentrations increase with age, whereas these are constant in the locus coeruleus; therefore iron could contribute to neurodegeneration in the substantia nigra more than in the locus coeruleus.5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
Connor, J. R., Boyer, P. J., Menzies, S. L., Dellinger, B., Allen, R. P., Ondo, W. G., & Earley, C. J. (2003) · Neurology · doi:10.1212/01.wnl.0000078887.16593.12 · Cited by 548
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Disease‐specific patterns of locus coeruleus cell loss
German, D. C., Manaye, K. F., White, C. L., Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N., & Mann, D. M. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320510 · Cited by 512
Research works printed but not linked: 5
- Arnsten, A. F. & Goldman-Rakic, P. S. (1987) J. Neural Transm. 24, 317-324.
- 10.1002/1531-8249(199910)46:4<598::aid-ana7>3.0.co;2-f · DOI
- Wilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L. & Lucius, R. (2003) FASEB J. 17, 500-502.12631585
- Blain, I., Slama, P., Giorgi, M., Tron, T. & Reglier, M. (2002) J. Biotechnol. 90, 95-112.12069196
- Marttila, R. J., Viljanen, M., Toivonen, E., Lorentz, H. & Rinne, U. K. (1990) Adv. Neurol. 53, 141-144.2239455
Cited by
Items 201–300 of 533
Methamphetamine increases basal ganglia iron to levels observed in aging
Melega, W. P., Laćan, G., Harvey, D. C., & Way, B. M. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f0d4f4 · Cited by 47
Iron as a cause of Parkinson disease – a myth or a well established hypothesis?
Friedman, A., Gałązka-Friedman, J., & Koziorowski, D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70817-x · Cited by 47
Song, R., Yin, S., Wu, J., & Yan, J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00025 · Cited by 46
Caverzán, M. D., & Ibarra, L. E. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134777 · Cited by 46
Direct visualization and characterization of the human zona incerta and surrounding structures
Lau, J. C., Xiao, Y., Haast, R. A. M., Gilmore, G., Uludaǧ, K., MacDougall, K. W., Menon, R. S., Parrent, A. G., Peters, T. M., & KHAN, A. R. (2020) · Human Brain Mapping · doi:10.1002/hbm.25137 · Cited by 45
The toxic metal hypothesis for neurological disorders
Pamphlett, R., & Bishop, D. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1173779 · Cited by 45
Neuromelanin in parkinsonian disorders: an update
Martín‐Bastida, A., Pietracupa, S., & Piccini, P. P. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1325883 · Cited by 45
Intracerebral Hemorrhage: The Effects of Aging on Brain Injury
Watson, N. J., Bonsack, F., & Sukumari‐Ramesh, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.859067 · Cited by 45
Association between Serum Copper Status and Working Memory in Schoolchildren
Zhou, G., Ji, X., Cui, N., Cao, S., Liu, C., & Liu, J. (2015) · Nutrients · doi:10.3390/nu7095331 · Cited by 44
Noradrenergic neuromodulation in ageing and disease
Krohn, F., Lancini, E., Ludwig, M., Leiman, M., Guruprasath, G., Haag, L., Panczyszyn, J., Düzel, E., Hämmerer, D., & Betts, M. J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105311 · Cited by 42
Poursani, E. M., Mercatelli, D., Raninga, P. V., Bell, J. L., Saletta, F., Kohane, F. V., Neumann, D., Zheng, Y., Rouaen, J. R. C., Jue, T. R., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01083-7 · Cited by 42
Cukierman, D. S., Lázaro, D. F., Sacco, P. S., Ferreira, P. R., Diniz, R., Fernández, C. O., Outeiro, T. F., & Rey, N. A. (2020) · Dalton Transactions · doi:10.1039/d0dt01138j · Cited by 42
Ficiarà, E., Munir, Z., Boschi, S., Caligiuri, M. E., & Guiot, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094479 · Cited by 42
A novel approach to quantify different iron forms in ex-vivo human brain tissue
Kumar, P., Bulk, M., Webb, A., van der Weerd, L., Oosterkamp, T. H., Huber, M., & Bossoni, L. (2016) · Scientific Reports · doi:10.1038/srep38916 · Cited by 40
Xing, Y., Sapuan, A. H., Martín‐Bastida, A., Naidu, S., Tench, C. R., Evans, J., Sare, G. M., Schwarz, S. T., Al–Bachari, S., Parkes, L. M., et al. (2022) · Movement Disorders · doi:10.1002/mds.28934 · Cited by 41
Schroeder, R. L., Double, K. L., & Gerber, C. (2015) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2015.02.001 · Cited by 41
Kastman, E. K., Willette, A. A., Coe, C. L., Bendlin, B. B., Kosmatka, K. J., McLaren, D. G., Xu, G., Canu, E., Field, A. S., Alexander, A. L., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2553-12.2012 · Cited by 40
“By contrast, there are many more neuromelanin cells in the locus ceruleus, which appear to buffer against excess iron accumulation through chelation (Zecca et al., 2004b).”
InfluentialMagnetic resonance imaging of brain cell water
Watanabe, T., Wang, X., Tan, Z., & Frahm, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-41587-2 · Cited by 40
Ferroptosis and pathogenesis of neuritic plaques in Alzheimer disease
Streit, W. J., Phan, L. T., & Bechmann, I. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000823 · Cited by 39
Liu, Y., Li, J., He, N., Chen, Y., Jin, Z., Yan, F., & Haacke, E. M. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116935 · Cited by 39
Mukherjee, S., & Panda, D. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00377 · Cited by 40
The history of the research of iron in parkinsonian substantia nigra
Friedman, A., & Gałązka-Friedman, J. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0894-8 · Cited by 40
Amit, T., Bar‐Am, O., Mechlovich, D., Kupershmidt, L., Youdim, M. B. H., & Weinreb, O. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.026 · Cited by 39
Copper-mediated DNA damage by the neurotransmitter dopamine and L-DOPA: A pro-oxidant mechanism
Rehmani, N., Zafar, A., Arif, H., Hadi, S. M., & Wani, A. A. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.01.020 · Cited by 38
Das, A., Sarwar, M. S., Hossain, M. S., Karmakar, P., Islam, M. S., Hussain, M. E., & Banik, S. (2018) · Clinical EEG and Neuroscience · doi:10.1177/1550059418772755 · Cited by 38
Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism
Chougar, L., Arsovic, E., Gaurav, R., Biondetti, E., Faucher, A., Valabrègue, R., Pyatigorskaya, N., Dupont, G., Lejeune, F., Cormier‐Dequaire, F., et al. (2022) · Movement Disorders · doi:10.1002/mds.28988 · Cited by 38
Newland, B., Wolff, P., Zhou, D., Wang, W., Zhang, H., Rosser, A., Wang, W., & Werner, C. (2016) · Biomaterials Science · doi:10.1039/c5bm00542f · Cited by 38
Billings, J. L., Hare, D. J., Nurjono, M., Volitakis, I., Cherny, R. A., Bush, A. I., Adlard, P. A., & Finkelstein, D. I. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00305 · Cited by 37
Liu, C., Zhang, C., Lo, S. Q., Ang, S. T., Chew, K. C. M., Yu, D., Chai, B. H., Tan, B. C. Y., Tsang, F., Tai, Y. K., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3262-17.2018 · Cited by 37
Iannitelli, A. F., & Weinshenker, D. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105287 · Cited by 37
Walker, T. A., Michaelides, C., Ekonomou, A., Geraki, K., Parkes, H. G., Suessmilch, M., Herlihy, A. H., Crum, W. R., & So, P. (2016) · Aging · doi:10.18632/aging.101069 · Cited by 37
Capucciati, A., Zucca, F. A., Monzani, E., Zecca, L., Casella, L., & Hofer, T. (2021) · Antioxidants · doi:10.3390/antiox10060824 · Cited by 36
“NM appears to be the main iron compound in dopaminergic neurons of the SN, since ferritin expression is very low in these neurons [9,83].”
BackgroundSelf-citationConvergence of Cannabis and Psychosis on the Dopamine System
Ahrens, J., Ford, S. D., Schaefer, B., Reese, D., KHAN, A. R., Tibbo, P. G., Rabin, R. A., Cassidy, C., & Palaniyappan, L. K. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.0432 · Cited by 36
Viktorínová, A., & Ďurfinová, M. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135627 · Cited by 36
Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology
Malovic, E., Ealy, A., Kanthasamy, A., & Kanthasamy, A. G. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab021 · Cited by 36
Considerations for measuring iron in post-mortem tissue of Parkinson’s disease patients
Hare, D. J., Gerlach, M., & Riederer, P. F. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0898-4 · Cited by 36
Laguna, A., Peñuelas, N., González-Sepúlveda, M., Nicolau, A., Arthaud, S., Guillard-Sirieix, C., Picón, M. L., Compte, J., Miquel-Rio, L., Xicoy, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53168-7 · Cited by 35
Deistung, A., Jäschke, D., Draganova, R., Pfaffenrot, V., Hulst, T., Steiner, K. M., Thieme, A. G., Giordano, I., Klockgether, T., Tunç, S., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcab306 · Cited by 35
Pesch, B., Casjens, S., Woitalla, D., Dharmadhikari, S., Edmondson, D. A., Zella, M. A. S., Lehnert, M., Lotz, A., Herrmann, L., Muhlack, S., et al. (2019) · Cells · doi:10.3390/cells8020096 · Cited by 35
Maresca, V., Flori, E., Cardinali, G., Briganti, S., Lombardi, D., Mileo, A. M., Paggi, M. G., & Picardo, M. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20543 · Cited by 34
Maâroufi, K., Save, É., Poucet, B., Sakly, M., Abdelmelek, H., & Had‐Aissouni, L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.003 · Cited by 34
Hwang, K., Langley, J. A., Tripathi, R., Hu, X. P., & Huddleston, D. E. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282684 · Cited by 33
Nigrostriatal iron accumulation in the progression of Parkinson’s disease
López‐Aguirre, M., Balzano, T., Monje, M. H. G., Esteban-García, N., Martínez‐Fernández, R., del Rey, N. L., Ciorraga, M., Sánchez‐Ferro, Á., Trigo‐Damas, I., Blesa, J., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00911-6 · Cited by 32
Differential regulation of estrogen in iron metabolism in astrocytes and neurons
Xu, M., Tan, X., Li, N., Wu, H., Wang, Y., Xie, J., & Wang, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27188 · Cited by 32
Zachariou, V., Bauer, C. E., Seago, E. R., Panayiotou, G., Hall, E. D., Butterfield, D. A., & Gold, B. T. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.016 · Cited by 32
Boag, M. K., Roberts, A., Uversky, V. N., Ma, L., Richardson, D. R., & Pountney, D. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042378 · Cited by 32
Stable iron isotope tracing reveals significant brain iron uptake in adult rats
Chen, J., Shahnavas, S., Singh, N. N., Ong, W.-Y., & Walczyk, T. (2012) · Metallomics · doi:10.1039/c2mt20226c · Cited by 32
Defining a role for hemoglobin in Parkinson’s disease
Freed, J., & Chakrabarti, L. (2016) · npj Parkinson s Disease · doi:10.1038/npjparkd.2016.21 · Cited by 32
Tian, S., Wang, B., Ding, Y., Zhang, Y. L., Yu, P., Chang, Y.-Z., & Gao, G. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117419 · Cited by 32
Non-invasive assessment of normal and impaired iron homeostasis in the brain
Filo, S., Shaharabani, R., Hanin, D. B., Adam, M., Ben-David, E., Schoffman, H., Margalit, N. S., Habib, N., Shahar, T., & Mezer, A. (2023) · Nature Communications · doi:10.1038/s41467-023-40999-z · Cited by 30
Vano, L. J., McCutcheon, R. A., Rutigliano, G., Kaar, S. J., Finelli, V., Nordio, G., Wellby, G., Sedlacik, J., Statton, B. K., Rabiner, E. A., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.06.013 · Cited by 29
Chen, J., Cai, T., Yan, L., Chi, J., Rong, S., He, C., Li, X., Zhang, P., Wang, L., & Zhang, Y. (2020) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-20-285 · Cited by 29
Key, J., Şen, N.-E., Arsović, A., Krämer, S., Hülse, R., Khan, N. N., Meierhofer, D., Gispert, S., Koepf, G., & Auburger, G. W. J. (2020) · Cells · doi:10.3390/cells9102229 · Cited by 30
Zhang, C., Tai, Y. K., Chai, B., Chew, K. C. M., Ang, E., Tsang, F., Tan, B. W. Q., Hong, E. T. E., Asad, A. B. A., Chuang, K., et al. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8451-0 · Cited by 29
Locus Coeruleus magnetic resonance imaging in cognitively intact elderly subjects
Giorgi, F. S., Lombardo, F. P., Galgani, A., Hlavata, H., Latta, D. D., Martini, N., Pavese, N., Ghicopulos, I., Baldacci, F., Coi, A., et al. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-021-00562-0 · Cited by 29
Neuromelanin and selective neuronal vulnerability to Parkinson’s disease
Filimontseva, A., Fu, Y., Vila, M., & Halliday, G. M. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.04.005 · Cited by 28
Molecular Understanding of Copper and Iron Interaction with α-Synuclein by Fluorescence Analysis
..., B., & Rao, K. S. J. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9076-4 · Cited by 28
Behl, T., Madaan, P., Sehgal, A., Singh, S., Anwer, M. K., Makeen, H. A., Albratty, M., Mohan, S., & BUNGAU, S. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020678 · Cited by 28
Mouse models of Parkinson's disease associated with mitochondrial dysfunction
Pickrell, A. M., Pinto, M., & Moraes, C. T. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.002 · Cited by 28
Ajibo, D. N., Orish, C. N., Ruggieri, F., Bocca, B., Battistini, B., Frazzoli, C., Orish, F. C., & Orisakwe, O. E. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03965-w · Cited by 27
Agarwal, R., Adhikary, S., Bhattacharya, S., Goswami, S., Roy, D., Dutta, S., Ganguly, A., Nanda, S., & Rajak, P. (2024) · Environmental Science Advances · doi:10.1039/d4va00062e · Cited by 26
Healy, S., McMahon, J. M., & FitzGerald, U. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.004 · Cited by 26
Quantifying the contrast of the human locus coeruleus in vivo at 7 Tesla MRI
Tona, K., van Osch, M. J. P., Nieuwenhuis, S., & Keuken, M. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0209842 · Cited by 26
Age-Mediated Transcriptomic Changes in Adult Mouse Substantia Nigra
Gao, L., Hidalgo‐Figueroa, M., Escudero, L. M., Díaz‐Martín, J., López‐Barneo, J., & Pascual, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062456 · Cited by 26
The decrease of NAD(P)H has a prominent role in dopamine toxicity
Giménez‐Xavier, P., Gómez-Santos, C., Castaño, E., Francisco, R., Boada, J., Unzeta, M., Sanz, E., & Ambrosio, S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.02.003 · Cited by 26
Zhang, D., Yao, J., Sun, J., Tong, Q., Zhu, S., Wang, J., Chen, L., Ma, J., He, H., & Wu, T. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223499 · Cited by 25
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease
Cai, W., Wakamatsu, K., Zucca, F. A., Wang, Q., Yang, K., Honarvar, N. M., Srivastava, P., Tanaka, H., Holly, G., Casella, L., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102414 · Cited by 25
Self-citationNew opportunities for antioxidants in amelioration of neurodegenerative diseases
Bhandari, U. R., Danish, S. M., Ahmad, S., Ikram, M., Nadaf, A., Hasan, N., Kesharwani, P., & Ahmad, F. J. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111961 · Cited by 25
Singh, P., & Bhat, R. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00650 · Cited by 25
Wakamatsu, K., Nakao, K., Tanaka, H., Kitahori, Y., Tanaka, Y., Ojika, M., & Ito, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102575 · Cited by 25
Bacchella, C., Nicolis, S., Dell’Acqua, S., Rizzarelli, E., Monzani, E., & Casella, L. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b03153 · Cited by 25
Madelung, C. F., Løkkegaard, A., Fuglsang, S. A., Marques, M. M., Boer, V. O., Madsen, K. H., Hejl, A., Meder, D., & Siebner, H. R. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00972-7 · Cited by 24
Gałązka-Friedman, J., Friedman, A., & Bauminger, E. R. (2009) · Hyperfine Interactions · doi:10.1007/s10751-009-9926-7 · Cited by 24
Chen, Y., Li, Y., Wang, S., Zhou, T.-T., Chen, N., & Yuan, Y. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03564-6 · Cited by 24
Carmona, A., Carboni, E., Gomes, L. C., Roudeau, S., Maass, F., Lenz, C., Ortega, R., & Lingor, P. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16040 · Cited by 24
Wakamatsu, K., Tanaka, H., Tabuchi, K., Ojika, M., Zucca, F. A., Zecca, L., & Ito, S. (2014) · Molecules · doi:10.3390/molecules19068039 · Cited by 24
Self-citationSpontaneous Formation of Melanin from Dopamine in the Presence of Iron
Hedges, D. M., Yorgason, J. T., Perez, A. W., Schilaty, N. D., Williams, B. M., Watt, R. K., & Steffensen, S. C. (2020) · Antioxidants · doi:10.3390/antiox9121285 · Cited by 23
Enlisting electrochemistry to reveal melanin's redox-related properties
Kim, E., Wang, Z., Phua, J. W., Bentley, W. E., Dadachova, E., Napolitano, A., & Payne, G. F. (2024) · Materials Advances · doi:10.1039/d3ma01161e · Cited by 23
Cui, S., Sun, H., Gu, X., Lv, E., Zhang, Y., Dong, P., Fu, C., & Zhu, C. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1889-z · Cited by 23
RetractedThe effect of iron nanoparticles on performance of cognitive tasks in rats
Sheida, E. V., Юрьевна, С. О., Miroshnikov, S. A., Sizova, E. A., Lebedev, S. V., Rusakova, E., & Notova, S. V. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-8531-6 · Cited by 23
The role of the LC-NE system in attention: From cells, to systems, to sensory-motor control
Torres, A. S., Robison, M. K., & Brewer, G. A. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106233 · Cited by 23
Neuromelanin-sensitive MRI for mechanistic research and biomarker development in psychiatry
Wengler, K., Trujillo, P., Cassidy, C., & Horga, G. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01934-y · Cited by 22
The Metabolic Fate of ortho-Quinones Derived from Catecholamine Metabolites
Ito, S., Yamanaka, Y., Ojika, M., & Wakamatsu, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020164 · Cited by 22
Imaging Parkinsonian Pathology in Substantia Nigra with MRI
Huddleston, D. E., Langley, J. A., Dušek, P., He, N., Faraco, C. C., Crosson, B., Factor, S. A., & Hu, X. P. (2018) · Current Radiology Reports · doi:10.1007/s40134-018-0272-x · Cited by 22
Glia Protects Neurons against Extracellular Human Neuromelanin
Depboylu, C., Matusch, A., Tribl, F., Zoriy, M. V., Michel, P. P., Riederer, P. F., Gerlach, M., Becker, S., Oertel, W. H., & Höglinger, G. U. (2007) · Neurodegenerative Diseases · doi:10.1159/000101846 · Cited by 22
Cross‐Scanner Harmonization of Neuromelanin‐Sensitive MRI for Multisite Studies
Wengler, K., Cassidy, C., van der Pluijm, M., Weinstein, J. J., Abi‐Dargham, A., van de Giessen, E., & Horga, G. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27679 · Cited by 21
Wakamatsu, K., & Ito, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-1490-3_2 · Cited by 21
Wang, H., Liu, Z., Liu, Y., Qi, Z., Wang, S., Liu, S., Dong, S., Xia, X., & Li, S. (2014) · ACTA SCIENTIAE VETERINARIAE · Cited by 20
Rosenblum, S. L., & Kosman, D. J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.855751 · Cited by 21
Kobayashi, H., Oikawa, S., Umemura, S., Hirosawa, I., & Kawanishi, S. (2008) · Free Radical Research · doi:10.1080/10715760802270334 · Cited by 20
Surówka, A. D., Wróbel, P., Adamek, D., Radwańska, E., & Szczerbowska‐Boruchowska, M. (2015) · Metallomics · doi:10.1039/c5mt00154d · Cited by 20
Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders
Bergsland, N., Tavazzi, E., Schweser, F., Jakimovski, D., Hagemeier, J., Dwyer, M. G., & Zivadinov, R. (2019) · CNS Drugs · doi:10.1007/s40263-019-00668-6 · Cited by 20
Hassanein, L., Mulvey, B., Blankenship, H. E., Tish, M., Korukonda, A., Liles, L. C., Sharpe, A. L., Paré, J., Villalba, R. M., Chen, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.07.530845 · Cited by 20
Zachariou, V., Bauer, C. E., Pappas, C. A., & Gold, B. T. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac382 · Cited by 19
Ward, W. C., Zucca, F. A., Bellei, C., Zecca, L., & Simon, J. D. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.01.013 · Cited by 19
Self-citationMa, Z., Zhou, Y., & Xie, J. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9309-8 · Cited by 19
Ironsmith: An automated pipeline for QSM-based data analyses
Zachariou, V., Bauer, C. E., Powell, D. K., & Gold, B. T. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118835 · Cited by 18
Ito, S., Napolitano, A., Sarna, T., & Wakamatsu, K. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02574-6 · Cited by 18
Beardmore, R., Durkin, M., Zayee‐Mellick, F., Lau, L. C., Nicoll, J. A. R., Holmes, C., & Boche, D. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12965 · Cited by 18
Liu, H., Su, B., Zhang, Z., Jia, S., Wang, J., Zhou, F., Liu, Y., Cao, Q., Tang, J., Ou, Z., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.02.009 · Cited by 18
Metadata
- Authors
- Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., Karatekin, E., Kleinman, M. H., Turro, N., Hornykiewicz, O., & Zucca, F. A.
- Affiliations
- Institute of Biomedical Technologies (IT)
- University of Vienna (AT)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-06-21
- Volume
- 101
- Issue
- 26
- Pages
- 9843-9848
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC470762
- OpenAlex
- W2116294955
- Cited by
- 495
- References
- 51
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 31 · 2023: 30 · 2022: 37 · 2021: 46 · 2020: 31 · 2019: 41 · 2018: 23 · 2017: 18 · 2016: 21 · 2015: 22 · 2014: 18 · 2013: 14 · 2012: 21
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron, copper, locus coeruleus, substantia nigra, Parkinson's disease, neuronal vulnerability, aging, neuromelanin, ferritin, ceruloplasmin, manganese superoxide dismutase, copper-zinc superoxide dismutase, iron mobilization, iron toxicity, brainstem
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Ceruloplasmin, Copper, Electron Spin Resonance Spectroscopy, Female, Ferritins, Homeostasis, Humans, Iron, Iron Chelating Agents, Locus Coeruleus, Male, Melanins, Middle Aged, Neuroglia, Neurons, Substantia Nigra, Superoxide Dismutase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.